# Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension

> **NCT06359873** · — · COMPLETED · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 58427 (actual)

## Conditions studied

- Atrial Fibrillation
- Hypertension,Essential
- Left Atrial Dilatation

## Interventions

- **DIAGNOSTIC_TEST:** CHA2DS2-VASc score, C2HEST score, and left atrial diameter (LAD)

## Key facts

- **NCT ID:** NCT06359873
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2023-05-01
- **Target enrollment:** 58427 (ACTUAL)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06359873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06359873, "Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06359873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*